Quick Comparison

AniracetamL-Theanine
Half-Life1-2.5 hours2.5-4.5 hours
Typical DosageStandard: 750-1500 mg daily in 2 divided doses. Must be taken with fat for absorption (fat-soluble). Some users take up to 3000 mg daily.Standard: 100-200 mg daily. With caffeine: 100-200 mg L-Theanine per 50-100 mg caffeine (2:1 or 1:1 ratio). Can be taken up to 400 mg daily safely.
AdministrationOral (capsules, powder). Must be taken with dietary fat for proper absorption due to lipophilicity.Oral (capsules, powder, naturally in green tea). 100% bioavailable orally.
Research Papers10 papers10 papers
Categories

Mechanism of Action

Aniracetam

Aniracetam is a positive allosteric modulator of AMPA receptors, binding to the allosteric site and slowing receptor desensitization, which prolongs excitatory postsynaptic currents and facilitates long-term potentiation. It also modulates group II metabotropic glutamate receptors (mGluR2/mGluR3), which regulate presynaptic glutamate release. Uniquely among racetams, aniracetam increases dopamine and serotonin release in the prefrontal cortex via modulation of monoamine transporter activity and vesicular release, contributing to its anxiolytic and mood-enhancing effects. It reduces GABAergic inhibition in the hippocampus through indirect modulation of GABA-A receptors, facilitating NMDA receptor activation and memory consolidation. The lipophilic phenylacetyl group enables rapid blood-brain barrier penetration.

L-Theanine

L-Theanine (gamma-glutamylethylamide) crosses the blood-brain barrier via the large neutral amino acid transporter (LAT1/SLC7A5) and exerts anxiolytic effects through multiple pathways. It increases GABA synthesis by serving as a substrate for glutamate decarboxylase (GAD), elevating inhibitory tone without directly binding GABA-A receptors — avoiding sedation. It modulates serotonin by increasing tryptophan hydroxylase (TPH2) activity and raises dopamine levels in the prefrontal cortex via inhibition of dopamine reuptake. L-Theanine antagonizes glutamate binding at AMPA and kainate receptor subtypes (GluA1-4, GluK1-5), reducing excitatory neurotransmission and excitotoxicity risk. This glutamate antagonism, combined with increased GABA, drives the characteristic increase in alpha brain wave power (8-14 Hz) in the posterior parietal and occipital cortex — the EEG signature of relaxed alertness. When co-administered with caffeine, L-theanine attenuates caffeine-induced increases in blood pressure and anxiety by modulating sympathetic nervous system activation through alpha-2 adrenergic receptor pathways, while caffeine's dopaminergic and adenosine-blocking effects on focus and attention are preserved.

Risks & Safety

Aniracetam

Common

Headache (mitigated by choline supplementation), mild gastrointestinal discomfort, insomnia.

Serious

No serious adverse effects documented at standard doses.

Rare

Anxiety or overstimulation in sensitive individuals, dizziness.

L-Theanine

Common

Very few side effects at standard doses. Mild drowsiness in some individuals.

Serious

None documented. Extremely safe with decades of human consumption data.

Rare

Headache, dizziness, gastrointestinal discomfort.

Full Profiles